Economists have shown that the cost to get one drug to market successfully is now more than $2.8 billion. This cost has been growing at 7.5 percent per year, more than doubling every ten years. Most of this cost is due to FDA regulation.
Silas Palmer research fellow and former Hoover research assistant Yuan Tian uses Hoover collections to uncover the history of European and North American medical missions to West China at the turn of the twentieth century.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.